Renewvax

Developer of vaccines to treat bacterial infections and antimicrobial resistance

placeLiverpool, England, United Kingdom calendar_todayFounded 2022 groups6 employees language renewvax.com

Registered entities

Social engagement

Social engagement: 460 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%

Recent activity

31 Mar 2026
Event
World Vaccine Congress 2026
24 Mar 2026
Event
World Vaccine Congress 2026
17 Mar 2026
Event
One Nucleus Annual Awards Dinner 2026
Coming soon